Cargando…
Intensive versus less-intensive antileukemic therapy in older adults with acute myeloid leukemia: A systematic review
To compare the effectiveness and safety of intensive antileukemic therapy to less-intensive therapy in older adults with acute myeloid leukemia (AML) and intermediate or adverse cytogenetics, we searched the literature in Medline, Embase, and CENTRAL to identify relevant studies through July 2020. W...
Autores principales: | Chang, Yaping, Guyatt, Gordon H., Teich, Trevor, Dawdy, Jamie L., Shahid, Shaneela, Altman, Jessica K., Stone, Richard M., Sekeres, Mikkael A., Mukherjee, Sudipto, LeBlanc, Thomas W., Abel, Gregory A., Hourigan, Christopher S., Litzow, Mark R., Michaelis, Laura C., Alibhai, Shabbir M. H., Desai, Pinkal, Buckstein, Rena, MacEachern, Janet, Brignardello-Petersen, Romina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009379/ https://www.ncbi.nlm.nih.gov/pubmed/33784346 http://dx.doi.org/10.1371/journal.pone.0249087 |
Ejemplares similares
-
Less intensive antileukemic therapies (monotherapy and/or combination) for older adults with acute myeloid leukemia who are not candidates for intensive antileukemic therapy: A systematic review and meta-analysis
por: Colunga-Lozano, Luis Enrique, et al.
Publicado: (2022) -
Prognosis of older patients with newly diagnosed AML undergoing antileukemic therapy: A systematic review
por: Hao, Qiukui, et al.
Publicado: (2022) -
Predictors of intensive care unit admission in patients with hematologic malignancy
por: Vijenthira, Abi, et al.
Publicado: (2020) -
When applying GRADE, how do we decide the target of certainty of evidence rating?
por: Zeng, Linan, et al.
Publicado: (2021) -
Under COVID of the night
por: Sekeres, Mikkael A.
Publicado: (2020)